Status:
TERMINATED
Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing
Lead Sponsor:
Mayo Clinic
Conditions:
Dyspnea
Heart Failure With Preserved Ejection Fraction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to utilize lung ultrasound to detect the development of extravascular lung water in patients undergoing clinically indicated invasive hemodynamic exercise stress testing for s...
Detailed Description
Exercise induced elevation of left ventricular (LV) filling pressures can be the source of chronic dyspnea. Ultimately, high LV filling pressure leads to the development of extravascular lung water (E...
Eligibility Criteria
Inclusion
- All adult patients (≥18 years) who are referred for invasive cardiac hemodynamic assessment
- Patients who have the capacity to understand and consent for the research study
Exclusion
- Patients with known interstitial lung disease or pulmonary fibrosis
Key Trial Info
Start Date :
November 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2019
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04019613
Start Date
November 8 2019
End Date
December 19 2019
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905